HomeBUSINESS
BUSINESS

Lenvima Filed for HCC in Taiwan: Eisai
(Dec.7.2017)

Eisai said on December 6 that it has submitted its cancer drug Lenvima (lenvatinib) for an additional indication of hepatocellular carcinoma (HCC) in Taiwan ...
(LOG IN FOR FULL STORY)